Schwazze
corporate_fare Company Profile
Schwazze (OTC:SHWZ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for SHWZ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-03-24, rated 9/10.
Recent high-impact activity:
- Schwazze Completes Major Asset Sale: 45 Dispensaries, 2 Facilities Acquired by Vireo Growth
Financial Snapshot
Fiscal year ended December 31, 2023
Revenue
$172.45M
Net Income
-$34.55M
Diluted EPS
-$0.66
Op. Cash Flow
$12.2M
Free Cash Flow
$4.34M
Gross Profit
$76.02M
Operating Income
$3.29M
Cash & Equivalents
$19.25M
Total Debt
$156.81M
Debt / Equity
1.31×
Net Margin
-20.0%
Shares Outstanding
73.97M sh
Source: 10-K · filed 2024-03-27 · accession 0001558370-24-004104
show_chartPrice Chart
Loading chart...
feed SHWZ - Latest Insights
SHWZ
Mar 24, 2026, 7:00 AM EDT
Price at Filing:
$0.000001
Real-time Price:
$0.00001
Change:
N/A
Market Cap:
$865.315